BTSGY yields 64.94% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, BTSGY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTSGY + PFE for your $10,000?
BTS Group Holdings Public Company Limited, together with its subsidiaries, engages in mass transit, property, media, and service businesses in Thailand. The company operates in three segments: Move, Mix, and Match. It operates and maintains BTS Sky Train system; constructs, operates, installs, and maintains electric rails; and train procurement services and other related services, as well as provides bus rapid transit services. The company also offers marketing solutions through offline and online media; advertising, digital, and sales services; system installation and integration services; and insurance brokerage services for offline and online distribution channels, as well as services related to rabbit card. In addition, the company offers investment in various businesses, such as restaurant operations, construction services, golf course services, and other services businesses. Further, it invests in the securities of other companies; provides architecture and engineering work consultancy services; and manages food and beverage businesses; provides electronic payment, electronic money, and bill payment services; develops software and provides technology and system integration services; and offers CRM loyalty program and coupon kiosks. The company was formerly known as Tanayong Public Company Limited and changed its name to BTS Group Holdings Public Company Limited in May 2010. BTS Group Holdings Public Company Limited was founded in 1968 and is based in Bangkok, Thailand.
Full BTSGY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.